Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress Read more about Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress
FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy Read more about FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment Read more about Prolia® (Denosumab) Phase 2 Extension Study Showed Continued Increase in Bone Mineral Density Over Eight Years of Treatment
Amgen to Present at the UBS Global Life Sciences Conference Read more about Amgen to Present at the UBS Global Life Sciences Conference
Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits Read more about Amgen Staff Volunteer Efforts Result in $5,000 For Each of Their Favorite Nonprofits
Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference Read more about Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
Amgen to Present at the Morgan Stanley Global Healthcare Conference Read more about Amgen to Present at the Morgan Stanley Global Healthcare Conference
Amgen to Present at the Baird Healthcare Conference Read more about Amgen to Present at the Baird Healthcare Conference
Amgen to Present at the Stifel Nicolaus Healthcare Conference Read more about Amgen to Present at the Stifel Nicolaus Healthcare Conference
Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign Read more about Award-Winning Actress Blythe Danner and Amgen Launch Act 2 Reduce Fractures(TM) Educational Campaign
